Angiofibroma

An angiofibroma is a non-cancerous growth made of fibrous tissue with many small blood vessels inside. These vessels can sometimes bleed.

Condition

What people with Angiofibroma report

Every report comes from a Lived member, sent anonymously.

Have you had Laser Therapy for Angiofibroma?

NameHow it went

About Angiofibroma

What It Is

An angiofibroma is a noncancerous growth made of fibrous tissue and small blood vessels. The name covers two quite different problems, so it helps to know which one is meant: small bumps in the skin, usually on the face, and a much rarer tumor that grows in the back of the nose. Skin angiofibromas are firm, dome-shaped bumps, usually smaller than 5 millimeters, that are skin-colored, pink or red. A single bump on the nose of an adult, called a fibrous papule, is common and harmless, although it can look like a mole or a skin cancer. Many small bumps across the nose and cheeks that begin in childhood are different: they are one of the most common signs of tuberous sclerosis complex, a genetic condition. Juvenile nasopharyngeal angiofibroma (JNA) grows in the nasopharynx, the space behind the nose above the throat, and mainly affects adolescent boys and young men. It does not spread to distant parts of the body the way a cancer can, but it has a rich blood supply and can push into nearby bone, the sinuses, the eye socket and, in advanced cases, the inside of the skull. Its typical signs are a nose blocked on one side and repeated nosebleeds.

Causes & Risk Factors

Angiofibromas form from a local overgrowth of fibrous tissue and blood vessels. What sets off any individual growth is not known, and nothing a person did causes one. Several facial angiofibromas usually point to an underlying genetic condition. The best known is tuberous sclerosis complex (TSC), caused by changes in the TSC1 or TSC2 gene, which can also affect the brain, kidneys, heart and lungs. Facial angiofibromas develop in about 80% of people with TSC, typically starting in childhood. Most people with TSC have no family history of it, because about two-thirds of cases come from a new gene change rather than from a parent. Angiofibromas also occur in multiple endocrine neoplasia type 1 (MEN1), an inherited syndrome of hormone-gland tumors, and less often in Birt-Hogg-Dubé syndrome, an inherited condition that also affects the lungs and kidneys. A single acquired angiofibroma, such as a fibrous papule of the nose, is not linked to a genetic syndrome. Pearly penile papules, tiny harmless bumps along the rim of the penis that many adult men have, are also a form of angiofibroma. JNA usually appears in the teenage years. Because it affects young males so strongly and the tumors carry receptors for male hormones (androgens), researchers suspect hormones play a part, but this is not proven. There is no known way to prevent it.

How It's Diagnosed

A dermatologist can often recognize skin angiofibromas by their appearance and pattern. When a bump could be something else, such as a mole or a basal cell carcinoma (a common, slow-growing skin cancer), a small skin biopsy settles the question. When several angiofibromas appear on a child's face, the next question is whether TSC or another syndrome lies behind them. That assessment includes a careful look at the rest of the skin, the nails, teeth, gums and eyes, and may lead to genetic testing and to scans of the brain, heart and kidneys, where TSC can cause growths that need monitoring of their own. For JNA, an ear, nose and throat specialist usually sees the mass when looking into the back of the nose. Imaging then maps it. A CT scan shows how far the tumor has worn into bone, and an MRI shows soft tissue, nearby major arteries and any extension toward the brain. An angiogram, an X-ray study of the blood vessels, shows which arteries feed the tumor. Unlike most tumors, JNA is generally diagnosed without a biopsy first, because cutting into it can cause heavy bleeding. The imaging also stages the tumor by how far it extends, which guides the choice of surgery.

Treatment Options

Skin angiofibromas are harmless and do not have to be treated. People treat them because of how they look, or because they bleed, itch or catch on things. A single bump can be removed by a dermatologist with a minor procedure such as shaving, excision, electrocautery or laser. For the many facial angiofibromas of TSC, sirolimus gel (Hyftor) is FDA-approved for adults and children 6 and older. Sirolimus belongs to the mTOR inhibitor family, medicines that block a growth signal that is overactive in TSC and are also used for other TSC-related growths. Applied to the affected skin twice a day, it reduces redness and flattens smaller bumps in many people; if there is no improvement after 12 weeks, the prescriber reconsiders it. It controls the lesions only while it is used, so they can return after stopping. The usual side effects are dry skin, irritation, itching and acne. Because sirolimus can harm a developing baby, anyone who could become pregnant needs effective contraception during treatment and for 12 weeks afterward. The prescriber will also explain sun and vaccine precautions. Lasers treat lesions that remain or that are larger and firmer, which tend to respond less to gel. Vascular lasers, such as pulsed dye laser, target redness, while ablative lasers, such as carbon dioxide (CO2) laser, resurface raised bumps; extensive ablative treatment often needs general anesthesia. No single laser has proven best, and because these lesions tend to come back, repeat sessions are expected. Some dermatologists combine laser with ongoing sirolimus gel. People with TSC who take oral everolimus, a related medicine, for kidney or brain growths often see their skin improve as well, although it is not approved for skin lesions alone. JNA is treated mainly with surgery. Most tumors can now be removed endoscopically, with a camera and instruments passed through the nostrils, which avoids cuts on the face. Larger tumors may need an open approach, sometimes combined with endoscopy. Before surgery, many people have embolization: a specialist passes a thin tube through the blood vessels and blocks the arteries feeding the tumor to reduce bleeding during the operation. Radiation therapy is reserved for tumors that extend inside the skull or around the major arteries, where surgery would be especially risky.

What to Expect

Skin angiofibromas linked to TSC are persistent. Treatment can make them much less visible, but it controls rather than cures them, and after removal they come back in many people, so most people use ongoing gel, periodic laser touch-ups or both. Visible facial lesions can affect confidence and how people feel they are seen, which is a legitimate reason to treat them. For people with TSC, the skin is usually one part of lifelong care shared among several specialists. A single fibrous papule, by contrast, is usually a one-time concern. With JNA, the work continues after surgery. Repeated bleeding before treatment can cause anemia (a low red blood cell count), which may need treatment of its own. The tumor comes back in roughly 13 to 46 out of 100 people, depending mainly on how large and extensive it was, so specialists arrange follow-up imaging, usually MRI. Finding leftover tissue does not automatically mean more surgery: in studies of advanced JNA, residual or returning tumor more often stayed stable or shrank than grew, and watching it with scans is often reasonable when it causes no symptoms.

When to Seek Help

Arrange a visit for frequent nosebleeds or a nose that stays blocked on one side, especially in a teenage boy or young man; these deserve an examination by an ear, nose and throat specialist. Also see a doctor if several small bumps appear on a child's face, which can be an early sign of TSC, or if a skin bump grows, bleeds or changes and you are unsure what it is. After treatment for JNA, contact the care team about returning nasal blockage, renewed nosebleeds, swelling of the cheek or changes in vision, which can signal regrowth. Get emergency care for a nosebleed that is very heavy, makes breathing difficult, or does not stop after 20 minutes of firm pressure.

Questions to Ask Your Doctor

  1. 1.Is this a single harmless bump, or could it be connected to a condition such as tuberous sclerosis complex?
  2. 2.Would genetic testing or other checks be useful for me or my child, and what would they look for?
  3. 3.What results can I realistically expect from sirolimus gel or laser, and how often will treatment need repeating?
  4. 4.How far does the tumor extend, and which surgical approach and embolization plan do you recommend?
  5. 5.What follow-up scans will I need after treatment, and which symptoms would suggest the tumor has come back?

Last reviewed • Oct 2026

Educational content, not medical advice.